NCT00109512 - Endometriosis Trial: Study of NBI-56418 in Endometriosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Endometriosis

Interventions

DRUG

NBI-56418 (GnRH antagonist)

DRUG

placebo

Trial Locations (15)

Site Reference ID/Investigator# 56274, Richmond

Site Reference ID/Investigator# 55212, Virginia Beach

Site Reference ID/Investigator# 55213, Winston-Salem

Site Reference ID/Investigator# 56267, Clearwater

Site Reference ID/Investigator# 56272, Louisville

Site Reference ID/Investigator# 56269, Oak Brook

Site Reference ID/Investigator# 56273, Chicago

Site Reference ID/Investigator# 56271, Peoria

Site Reference ID/Investigator# 56270, Champaign

Site Reference ID/Investigator# 55211, Arlington

Site Reference ID/Investigator# 56268, Sandy City

Site Reference ID/Investigator# 56266, Phoenix

Site Reference ID/Investigator# 55210, San Diego

Site Reference ID/Investigator# 55214, San Ramon

Site Reference ID/Investigator# 56275, Spokane